Class IIOngoingD-0147-2023
Drug recall · January 25, 2023
Olopatadine HCl Ophthalmic Solution recall
Why: CGMP Deviations:
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Olopatadine HCl Ophthalmic Solution, USP 0.1%, 5 mL per dropper bottle, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-105-05
- Lots / codes
Lot: Lot 1B41A, EXP 1/31/2023
- Quantity
- 31,073 bottles
- Company
- Akorn, Inc., Gurnee, IL
- Distribution
- Nationwide in the USA
- Initiated
- October 13, 2022 · Voluntary: Firm initiated
- Classified
- January 13, 2023
- Reported
- January 25, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIOngoingJan 25, 2023AK-POLY-BAC brand of Bacitracin cand Polymixin B Sulfate Ophthalmic Ointment USPAkorn, Inc. · D-0132-2023Class IIOngoingJan 25, 2023Artificial Tears OINTMENTAkorn, Inc. · D-0133-2023Class IIOngoingJan 25, 2023Artificial Tears SolutionAkorn, Inc. · D-0134-2023Class IIOngoingJan 25, 2023Betaxolol Ophthalmic SolutionAkorn, Inc. · D-0135-2023Class IIOngoingJan 25, 2023Ciprofloxacin Ophthalmic SolutionAkorn, Inc. · D-0136-2023Class IIOngoingJan 25, 2023Cromolyn Sodium Ophthalmic SolutionAkorn, Inc. · D-0137-2023Class IIOngoingJan 25, 2023ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5%Akorn, Inc. · D-0138-2023Class IIOngoingJan 25, 2023Erythromycin Ophthalmic Ointment USPAkorn, Inc. · D-0139-2023Class IIOngoingJan 25, 2023GONAK Hypromellose Ophthalmic Demulcent SolutionAkorn, Inc. · D-0140-2023Class IIOngoingJan 25, 2023Ketorolac Tromethamine Ophthalmic SolutionAkorn, Inc. · D-0141-2023Class IIOngoingJan 25, 2023Levofloxacin Ophthalmic Solution 0.5%Akorn, Inc. · D-0142-2023Class IIOngoingJan 25, 2023Lidocaine Hydrochloride Jelly USPAkorn, Inc. · D-0143-2023
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Olopatadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.